TABLE 1 –

UTILIZATION AND SATISFACTION WITH PHARMACOLOGIC TREATMENTS IN INDIVIDUALS WITH IBS-C AND IBS-D

	% having ever tried	Very Satisfied	Somewhat Satisfied
IBS-C (n = 1,667)
Non-Prescription Medications
Fiber	69.5%	12.0%	39.0%
Non-prescription laxatives (PEG, bisacodyl, senna, etc)	62.6%	13.6%	47.1%
Stool softener (Colace, etc)	60.2%	10.0%	45.3%
Prescription Medications
FDA approved prescriptions for IBS-C (linaclotide or lubiprostone)	18.7%	25.3%	31.7%
Prescription laxatives (lactulose, etc)	11.2%	16.7%	33.9%
IBS-D (n = 1,587)
Non-Prescription Medications
Loperamide	49.5%	18.2%	49.2%
Fiber	43.6%	7.9%	33.4%
Bismuth subsalicylate	41.8%	8.9%	36.8%
Simethicone	29.9%	12.9%	41.8%
Prescription Medications
FDA approved prescription medication for IBS-D (alosetron or rifaximin)	Alosetron: 7.5% Rifaximin: 4.5%	Alosetron: 26.1% Rifaximin: 20.8%	Alosetron: 33.6% Rifaximin: 30.6%